VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
Disease of temporal bone.ppt new copy
1. Diseases of the Temporal Bone
INCLUDING GRANULOMAS (SYSTEMIC BONE DISEASE, INFECTIVE
AND GRANULOMATOUS DISEASE, AUTOIMMUNE INNER EAR DISEASE)
DR. RAJIV MAHASETH
MS ORL- HNS, 1ST
Year Resident
GMSM Academy of ENT – Head & Neck Studies
MMC-TUTH, IOM
2. Road map
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
•Systemic bone diseases
•Infective and granulomatous disease
•Autoimmune inner ear disease
3. Systemic bone diseaseSystemic bone disease
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Paget’s disease
Osteogenesis imperfecta
Fibrous dysplasia
Osteopetrosis
Neurofibromatosis
Craniofacial dysostosis
Osteopathia striata
4. Paget’s Disease
1876 - Sir James Paget - Osteitis deformans
1888 - Sir Jonathan Hutchinson referred osteitis
deformans as Paget's disease of bone
Progressive,focal disorder of bone remodelling
▪ Osteoclastic - Bone resorption
▪ Osteoblastic - Bone deposition
Clinical Presentation
▪ Bone pain, stiffness and fatiguability
▪ Enlargement of skull, pelvis, tibia and femur
www. Google.com/image
Disease of temporal bone - Dr Rajeev Mahaseth 2017
(Scott & Brown 7th
edition)
5. 2nd
most common bone disease after
osteoporosis
Affects -3 % of population > 40 yrs
- 11 % > 80 yrs
Male : Female = 3:2
Common : Britain, Australia, New
Zealand,
North America
Uncommon: Asia (Non-white race)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Paget’s disease contd.
(www.google.com/image)
6. Etiology :
Unknown
Inherited as autosomal dominant
Slow viral infection
Polyclonal antibodies reveal paramyxovirus antigens
in osteoclasts
Monoclonal antibodies - Measles, Human
Parainfluenza Virus
Electron microscopic study
- Fingerprint pattern of osteoclast
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Paget’s disease contd.
(Cummings 6th
edition)
7. Paget’s disease contd.
Multinucleated osteoclast
Courtesy of Pierre Delmas, MD.
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Bone affected
Pelvis > Femur >Skull > Tibia >Vertebrae
> Clavicle > Humerus
Phases:
Osteolytic - Mixed - Osteoblastic
- Lamellar remodeling (Temporal
Bone)
Bossing of temporal bone
Histology
Periosteum - Enchondral - Endosteal
layer
8. Clinical Feature
Bilateral progressive hearing loss: 13-40%
Sensorineural , mixed or conductive
Bone pain - constant deep boring
Joint stiffness and fatiguability
Vestibular symptoms - 20- 30%
- May present with vertigo
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Paget’s disease contd.
(Cummings 6th
edition)
9. Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Courtesy of Pierre Delmas, MD
Skull
enlargement
Dilated
scalp
veins
Paget’s disease contd.
10. Diagnosis :
Incidental finding in x - ray
Early stage: Osteolytic lesion
Advanced stage:
Bone density
Abnormal architecture
Overgrowth
Microfractures
CT Scan:
Temporal bone - washed out appearance of
petrous apex
Obliteration of otic capsule , narrowing of IAC
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott & Brown 7th
edition)
Paget’s disease contd.
11. Courtesy of Pierre Delmas, MD.
Disease of temporal Bone - Dr Rajeev Mahaseth
2017
Early Stage
(Osteoporosis
Circumscripta)
Lytic
border
Diffuse
sclerotic
changes
Advanced Stage
(Cotton wool skull)
Paget’s disease contd.
12. Laboratory tests
Marker of new bone formation
▪ Alkaline phosphatase
Elevated markers of bone resorption:
▪ Urinary hydroxyproline/creatinine
▪ Urinary and serum deoxypyridinoline
▪ C - telopeptide
▪ N - telopeptide )
Bone scan to assess extent of
disease
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott & Brown 7th
edition)
Paget’s disease contd.
www. google.com/image
13. Pain from site of known Paget`s disease
Early, potentially deforming disease
Osteolytic lesions in weight bearing bones
Skull disease
Complications:
a) Progressive neurological syndrome
b) Fissure fractures
c) Immobilization hypercalcaemia
d) High-out put cardiac failure
(Scott & Brown 7th
edition)
Indications forTreatment
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
14. Indications
Age <55yrs
Serum alkaline phosphate/urine hydroxyproline > 2
times
6 months prior to joint replacement surgery
Treatment
Physiotherapy
Antiresorptive therapy (Bisphosphonates )
- Tab Alendronate 40mg/day PO OD for 6 mths
Calcitonin was previously used, alternative
therapy
Analgesics
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott & Brown 7th
edition)
Paget’s disease contd.
16. Hereditary disorder of collagen synthesis
Incidence : 2 - 15/100000 births
Type 1
AD,Mild
Blue sclera, non deforming fracture
Normal stature, hearing loss
Type 2
Severe form, multiple fractures in utero
Still birth
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/ima
ge)
(Cummings 6th
edition)
OSTEOGENESIS IMPERFECTA
17. Type 3
Multiple fracture, progressive bone deformity
Hearing loss
Type 4
Similar to type 1 but there is white sclera
95% spontaneous fracture
50-60% hearing loss
Hypermobility/laxity of joints
Thin skin/subcutaneous bruising
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Cummings 6th
edition)
Osteogenesis imperfecta contd.
18. Clinical Feature
▪ 95% spontaneous fractures
▪ 85% blue sclera
▪ 50-60% hearing loss
▪ Hypermobility/laxity of joints
▪ Thin skin/subcutaneous bruising
CHL accompanies blue sclera appear in
- 20-25 yrs of age
SNHL seen in 40 % of patients - grey/white
sclera
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Cummings 6th
edition)
(www.google.com/ima
ge)
Osteogenesis imperfecta contd.
19. Investigations
Level of FGF 23 is raised
PCR - mutations of the gnas gene
Low serum phosphate
Radiology:
Enlarged temporal bone
Sclerosis(23%)
Ground glass appearance (56%)
Cystic lesion(21%)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/ima
ge)
Osteogenesis imperfecta contd.
20. History of fracture after minor trauma
Positive family history
Blue sclerae
Early onset of hearing loss
Stapes footplate - Thick, soft, chalk-like/granular,
fixed
Stapedectomy - Similar result otosclerosis
Treatment
- Biphosphonate
Disease of temporal Bone - Dr Rajeev Mahaseth
2017
(Cummings 6th
edition)
D/Dwith
otosclerosis
21. FIBROUS DYSPLASIA
▪ 1900 - Von Recklingshausen - Ostitis Fibrosa
▪ Genetic noninherited disease
▪ Somatic activating missense mutations
of GNAS1
▪ Age – 2 – 5th
decade
▪ Tumour like lesion - Replacement of normal
bone with cellular connective tissue
Types:
Monostotic : Skull base in 15 % ,maxilla .
mandible
Polyostotic : More than one bone lower
limbs,skull Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 6th
edition)
(www.google.com/image)
22. McCune-Albright syndrome
Polyostotic fibrous dysplasia
Skin hyperpigmentation
Endocrine dysfunction
Presentation
Skull base involved in 15 % cases
1/3rd cases are located in maxilla or
mandible
Palpable visible swelling in 75 % cases
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Fibrous dysplasia contd.
24. Presentation
Pain
Progressive hearing impairment - 57%
Localized temporal bone swelling - 51%
Bony occlusion of EAC - 42%
SNHL (erosion of otic capsule) ,pain,
vertigo
VII Nerve paralysis
Decreased vision – compression of optic
nerve
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Fibrous dysplasia contd.
25. Differential Diagnosis
Ossifying fibroma
Histiocytosis X
Paget’s disease
Aneurysmal bone cyst
Giant cell tumour
Brown tumour of hyperthyroidism
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Fibrous dysplasia contd.
26. Treatment
No known conservative treatment
Surgery
Curettage
External auditory meatus stenosis
Decompression of optic nerve
Radiotherapy :
Predispose to malignant degeneration
(Scott Brown 6th
edition)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Fibrous dysplasia
contd.
27. OSTEOPETROSIS
Rare genetic disorder
Defective osteoclast
- Failure of normal bone resorption
Normal bone formation by osteoblast
Thick, dense, brittle bones
Malignant
AR, rapidly progressive, Infancy
Encroachment of bone marrow - Anemia,
thrombocytopenia, susceptibility to infection,
hepatospleenomegaly
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/imag
e)
(Cummings 6th
edition)
28. Osteopetrosis contd.
Optic atrophy, facial paralysis, SNHL,
hydrocephalus, mental retardation
AD type1
Rare disorder , asymptomatic
Some have pain and hearing loss
No fracture
AD type 2 (Marble bone disease)
Frequent type with normal life expectancy
May be asymptomatic
Increased fracture of bones
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
29. Otological manifestation
Dense calcified cartilage
Non-pneumatized mastoid
Fetal form stapes
Normal inner ear
Dehiscence of tympanic segment of VII Nerve
Facial nerve paralysis : -
Unilateral/Bilateral
Recurrent AOM, CHL, SNHL
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Osteopetrosis contd.
(Cummings 6th
edition)
30. Radiological:
Increase density all bones
Increase serum acid phosphatase
Treatment
Not definitive
Steroid
Interferon
BMT
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Osteopetrosis contd.
(Cummings 6th
edition)
31. Infective and granulomatous Disease
Tuberculosis
Syphilis
Sarcoidosis
Histiocytosis X
Wegener’s
granulomatosis
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
32. TUBERCULOSIS
Chronic granulomatous infection
Age: 1 - 5 yrs
Incidence : 0.05 – 0.9 % of COM cases
Etiology: M. tuberculosis, M.Bovis, M.avium,
M.fortuitum
Risk factors: Active pulmonary tuberculosis, HIV
infection
Mode of transmission:
Hematogenous/Lymphatic
Eustachian tube
Intracranial, extracranial infection
Maternal systemic tuberculosisDisease of temporal Bone - Dr Rajeev Mahaseth 2017
(Cummings 6th
edition)
33. Diagnosis
Chronic otorrhoea resistant to usual antibiotic
treatment, surgery
Non tender high jugular chain lymphadenopathy, cold
abscess
Otoscopic examination
TM thickened ,landmark obliterated
Multiple perforation in TM with seropurulent
discharge
Middle ear mucosa - Pale
Conductive hearing loss
Effusion in middle ear & ossicles destructionDisease of temporal Bone - Dr Rajeev Mahaseth 2017
(Cummings 6th
edition)
Tuberculosis contd.
34. Otic capsule – Loss of auditory and vestibular
function
Histopathology
Granuloma with Langerhans cells – 1/3rd
case
Acid fast organism
Culture – Gold standard
Skin test , biopsy & PCR - TB
CT Scan – Soft tissue in middle ear,
intracranial/extracranial foci
ANCA (Antineutrophil cytoplasmic antibody) - WG
Tuberculosis contd.
(Cummings 6th
edition)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
35. Management
Antituberculous therapy - Dry ear in 1-3 months
Ear surgery minimal role
Complications
Profound SNHL
Facial paralysis
Petrous apicitis
Labyrinthitis, meningitis
Post auricular abscesses
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 7th
edition)
Tuberculosis contd.
36. SYPHILIS
Congenital and acquired syphilis affect middle ear
Less frequently seen in clinical practice
Male : Female – 4:1
Acquired form 25 times more frequent than congenital
SNHL (sudden/fluctuating ) tinnitus & vertigo
Systemic feature
- Cardiac and aortic involvement
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 6th
edition)
37. Syphilis contd.
Early syphilis:
Congenital bilateral hearing loss – 50 %
Secondary syphilis
- Transient vestibular symptoms (Positional
with tinnitus)
- Ocular palsy ,facial paralysis
SNHL – High frequency involved
Speech descrimination worse
Caloric response reduced
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
38. Late syphilis: 10 - 50 yrs of primary infection
Otological features :
SNHL – B/L in congenital , U/L in acquired
Onset of aural symptoms :
- Sudden, fluctuant , episodic vertigo
Severe vestibular damage
- Imbalance, ataxia
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 6th
edition)
Syphilis contd.
39. Hennebert’s sign
Ocular deviation with positive or negative pressure in
external auditory canal
Fistula between middle and inner ear due to rarefying
osteitis
Tullio’s sign
Transient vertigo and nystagmus due to exposue to loud
sound
Diagnosis:
VDRL, TPHA, TPI, FTA-ABS
CSF examination - Raised globulin, IgG level &
lymphocytosisDisease of temporal Bone - Dr Rajeev Mahaseth 2017
Syphilis contd.
40. Treatment:
Penicillin - 600000units I/M OD x 21 days
Probenecid - 500mg x 6hrly
Ampicillin
- 1.5 gm x 6hrly x 4wks.
Prednisolone
- 30mg x 8hrly x 4wks (Jarish –Herxeimer rxn)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Syphilis contd.
41. Sarcoidosis
Rare systemic granulomatous disease of unknown
etiology
Non-caseating granuloma
Female predominance
Onset - 3rd
- 4th
decade
Bilateral hilar lymphadenopathy, cough and
granulomatous skin rash
Organs: Parotid gland, facial nerve, nasal cavity and
larynx
Uveitis 80 %, lymphadenopathy 55 %, parotid swelling
20 %,
facial nerve palsy 43%
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 6th
edition)
42. Otological Feature
SNHL – sudden fluctuating or progressive
vestibular dysfunction
Granulomatous disease external , middle ear &
mastoid
PTA - Low or high frequency hearing loss
Heerfordt syndrome
Parotitis, uveitis, facial nerve paralysis and
pyrexia
Histopathology
Perivascular lymphocytic infiltration and
granulomatous
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott Brown 6th
edition)
Sarcoidosis contd.
44. Histiocytosis X
Proliferation of cytologically benign histiocytes,
lymphocytes, eosinophlis in the affected tissue
Immunologic dysfunction
Organs: Reticuloendothelial system
3 types:
Eosinophilic granuloma
Hand-Schuller-Christian disease
Letterer-Siwe disease
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
45. Eosinophilic granuloma
Children , young adults
Male : Female - 2 : 1
Osteolytic lesion - Femur , pelvis , scapula, vertebrae
,ribs, mandible
Maxilla of skull
Clinical features:
Asymptomatic
Local Pain
Local swelling
Pathologic fracture
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Histiocytosis x contd.
46. Histopathology :
• Sheets of histiocytes
• Scattered eosinophils
• Plasma cells
• Areas of haemorrhage
• Necrosis with giant cell
Radiological appearance
• Punched out / lytic appearance
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
www.google.com/image
Histiocytosis x contd.
47. Hand-Schuller Christian disease
Multiple focal lesions
Early onset (<5yrs)
Common site – Skull bone
Destruction of temporal bone
- Secondary infection & otorrhoea
Systemic manifestation
Fever / Recurrent URTI
Otitis media
Cervical Lymphadenopathy,
hepatosplenomegaly
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
www.google.com/image
Histiocytosis x contd.
48. Letterer- Siwe Disease
Disseminated disease
Early onset (< 3 yrs)
Multiple organ involvement (Skin,
Lymph node, viscera)
Systemic manifestation:
Fever
Eczema like rash ,oral lesions
Lymphadenopathy
Multiple bony lesion
Respiratory failure- pulmonary
infiltration
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Cummings 6th
Edition)
Histiocytosis x contd.
(www.google.com/image)
49. Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Letterer- Siwe Disease contd.
Otological manifestation (15-61%)
Otorrhoea
Post auricular swelling, hearing loss, vertigo
Granulation /Polyp in EAC
Diagnosis
Inflammatory disorder not responding to antibiotic
Bilateral destructive ear disease
High ESR
Immunohistochemistry
Treatment
Aural polypectomy +/- steroid
Low dose chemotherapy
Histiocytosis x contd.
50. Autoimmune inner ear
disease
1. Vasculitis
▪ Wegener
granulomatosis
▪ Polyarteritis nodosa
▪ Temporal arteritis
▪ Cogan syndrome
▪ Behcet’s disease
2. Relapsing
polychondritis
3. Systemic lupus
erythmatosis
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
4. Immunodeficiency
disease
T cell deficiency
B cell deficiency
Disorder of phagocytosis
Complement system
disorder
51. Wegener’s Granulomatosis
Friedrich Wegener – German pathologist
Also called as Granulomatosis with polyangiitis
Age : 15 - 73 yrs
Necrotizing vasculitis small to medium sized vessels
Triad : Airway, lung & renal disease
Clinical features:
Epistaxis, nasal obstruction, crusting
Saddle nose deformity (perforated septum)
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott- Brown 7th
edition)
(www.google.com/ima
ge)
52. Wegener’s Granulomatosis
contd.
Otological features:
Ear involved in 15 - 35%
Seromucinous otitis media, frank otorrhoea
Necrotizing granulation tissue - Tympanic
cavity
TM - Multiple perforations (granulation)
Rapidly progressive SNHL
Loss of vestibular function
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott- Brown 7th
edition)
54. Polyarteritis nodosa
Systemic necrotizing vasculitis of small and medium
sized arteries
Male : Female - 3:1
Renal, coronary, hepatic and visceral circulation
involved
Otological feature:
SNHL - Sudden, bilateral symmetrical
CHL - Middle ear granulation
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(Scott-Brown 6th
edition)
55. Polyarteritis nodosa contd.
Lab tests :
Anaemia, raised ESR
Leukocytosis
Treatment
Systemic steroid
Immunosuppressive drug - Chlorambucil
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
56. Temporal arteritis
Older age group
Vasculitis of extracranial arteries
Aneurysm
formation Stenosis Occlusion
Features:
Pyrexia
Bitemporal headache
Tender palpable thickening of
temporal arteries
Blindness: 30% (Ophthalmic artery)Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
57. Temporal arteritis contd.
Otological features:
Hearing loss (rapid, progressive,
vertigo)
Lab.tests:
ESR
Serum globulin raised
Biopsy
Ultrasound/ Doppler help to identify
involved area
Treatments:
Systemic steroidsDisease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
58. Cogan Syndrome
Dr. David Cogan in 1945
Rare, autoimmune, young adults
Non syphilitic interstitial keratitis
Fluctuant, aggressive cochleovestibular
damage
Acute episode
- Nausea, vomiting, tinnitus followed by
SNHL
Otological features:
- B/L SNHL (Progressive , fluctuating
,episodic )
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
(Ballenger’s 17th
edition)
59. Cogan`s Syndrome contd.
Ocular symptoms:
▪ Excessive lacrimation,
▪ Photophobia
▪ Blurred vision
Treatment:
▪ Steroid
▪ Immunosuppresive drugs
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
60. Behcet’s disease
Prof. Hulusi Behcet named in 1973
Uncommmon
Chronic relapsing inflammatory
disorder
Recurrent mouth ulcers (89%)
Genital ulceration
Inflammed eyes
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
61. Behcet’s disease contd.
Otological:
Slow progressive, bilateral SNHL
Vestibular symtoms
Treatment:
Immunosuppresive
Steroids
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
62. Relapsing polychondritis
Rare disease of episodic inflammation
Degeneration of multiple cartilagenous structure
Pearson coined the term in 1960
Pathology
Cartilage and proteoglycan rich structures
(eyes and cardiovascular system)
Neutrophil infilteration
Loss of basophilia of cartilage
Etiology:
Autoimmune
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
(www.google.com/image)
63. Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Relapsing polychondritis contd.
65. Clinical presentation
Otological
Pinna involved in 89 %
Eustachian tube - Otitis media with effusion
Inner ear - Hearing loss and dysequilibrium
Nasal chondritis:
Pain, feeling of fullness , sudden painless saddle
deformity
Larynx and trachea
Hoarseness , tenderness, airway obstruction
Occular inflammationDisease of temporal Bone - Dr Rajeev Mahaseth 2017
Relapsing polychondritis contd.
66. Outcomes
Follows a course of acute exacerbation and
remission
Treatments
I. Medical
Steroids – Prednisolone 30-60mg/daily
Immunosupressive
( Azathioprine,Methotrexate)
Anti-CD4monoclonal antibody,
Minocycline.
II. Surgical
TracheostomyDisease of temporal Bone - Dr Rajeev Mahaseth 2017
Relapsing polychondritis contd.
67. Systemic lupus erythematosus
Multisystem connective tissue disorder
Etiology:
Autoimmune
Immune complex deposition
Otological features
Bilateral SSNHL - 8 %
Loss of spiral ganglion cell and hair cell and
atrophy of the
stria vascularis
Circulating immune complex sludge in stria
vascularis
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
68. Systemic lupus erythematosus
contd.
Lab Tests:
Antinuclear antibody
Anti dsDNA
Anaemia
Raised ESR
Treatment:
Steroids - Prednisolone 40 mg daily for 2 wks
Plasma exchange at 6 months interval
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
69. References
1. Scott-Brown 6th
& 7th
edition
2. Cumming’s otorhinolaryngology, 6th
edition
3. Ballenger’s otorhinolaryngology 17th
edition
4. https://scholar.google.com
5. Current Diagnosis and treatment 3rd
edition
6. Glasscock and sambough surgery of ear 6th
edition
Disease of temporal Bone - Dr Rajeev Mahaseth 2017
Editor's Notes
History This drawing of Paget&apos;s first patient, published in his original paper, demonstrates the characteristic appearance that may occur with severe disease. In his original description, Paget wrote, &quot;The disease begins in middle age or later (and) affects most frequently the long bones of the lower extremities and the skull in shape, size.... The bones enlarge and soften, and those bearing weight yield and become unnaturally curved and misshapen.“1 At the bottom of the slide, a marked increase in hat size is apparent.
Recent evidence supports genetic and environmental etiologic factors.2
References
The Paget Foundation. Available at: www.paget.org/Information/slide/paget_diag.ppt. Accessed August 10, 2005.
Altman RD. Paget’s disease of bone. In: Coe FL, Favus MJ, eds. Disorders of Bone and Mineral Metabolism. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:985-1020.
It is caused by the excessive breakdown and formation of bone, followed by disorganised bone remodelling.
This causes affected bone to weaken, resulting in pain, fractures and arthritis in the joints near the affected bones.
Paramyxovirus – Measles and RSV
Paget’s Disease: An Osteoclast-Mediated Disorder
Osteoclasts play a crucial role in certain metabolic bone diseases, such as Paget’s disease and osteoporosis.1
The constant renewal of the skeleton entails a process called bone remodeling. In this process, osteoclasts remove old bone and osteoblasts form new bone. The osteoclasts are responsible for bone resorption, while the osteoblasts lay down new bone in the resorbed areas. This new bone later mineralizes.2
In affected areas there is an increase in both the size and number of osteoclasts (as shown on the left). The image on the right shows that pagetic osteoclasts are also multinucleated and can contain up to 100 nuclei per cell.1
References
Siris ES, Roodman GD. Paget’s disease of bone. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003:495-506.
Roodman GD, Windle JJ. Paget disease of bone. J Clin Invest. 2005;115:200-208.
Paget’s Disease: Clinical Presentation (growing periosteal blood flow increase intraosseous pressure—stimulate bone pain fibres)
Paget’s disease is usually mild or symptomatic,1,2 and is most commonly found incidentally during examination for another complaint.1
Hearing loss high frequency attributed to loss in bone density narrow EAC and nerve compression
In one typical diagnostic scenario, an elderly person suffers a broken bone in an accident and a radiologist recognizes pagetic lesions in the x-rays. Another example is a patient who presents with abdominal pain and is found to have Paget’s disease on radiography.
Symptoms and complications of Paget’s relate to the site and extent of the disease and include bone, muscle, or joint pain; fractures; bone deformity; osteoarthritis; hearing loss; and dental complaints such as tooth loosening, all of which can contribute to a significantly decreased quality of life.1-4
Pain related to osteoarthritis in a hip or knee adjacent to a pagetic bone is a common complaint among patients with Paget’s disease.1
Bone pain, when present, is often mild to moderate; it often persists during the night, a feature that generally differentiates it from osteoarthritis.1
Pain in the tibia or femur may be aggravated by weight bearing.1
Dental problems such as loosening of the teeth or swollen, infected gums can occur in patients with Paget’s disease in the skull.4
References
Siris ES, Roodman GD. Paget’s disease of bone. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003:495-506.
Altman RD. Paget’s disease of bone. In: Coe FL, Favus MJ (eds). Disorders of Bone and Mineral Metabolism. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:985-1020.
Gold DT, Boisture J, Shipp KM, et al. Paget’s disease of bone and quality of life. J Bone Miner Res. 1996;11:1897-1904.
Ankrom MA, Shapiro JR. Paget’s disease of bone (osteitis deformans). J Am Geriatr Soc. 1998;46:1025-1033.
Paget’s Disease in the Skull
Typical changes in the skull associated with Paget’s disease include diffuse enlargement, and dilated scalp veins. Some patients may show frontal bossing or knobby deformity, or there may be enlargement of the maxilla or mandible.
Diagnosing Paget’s Disease: Tests
Diagnosis of Paget’s disease includes clinical, radiological, biochemical, and, in some rare cases, histological investigations.1,2
Diagnosis usually involves measurement of biochemical markers associated with increased bone turnover, especially serum alkaline phosphatase. In rare cases, bone biopsies may be required to establish a diagnosis.1,2
Biomarkers associated with increased bone measures provide a more immediate indication of response to therapy than do markers of bone formation.1
It is important to note that alkaline phosphatase can be elevated in other disorders, notably vitamin D deficiency, osteomalacia, and gall bladder and liver disease, which must be ruled out.
Radiographic findings of Paget’s disease are characteristic and rarely confused with x-ray findings suggestive of other diseases. Osteolytic lesions in long bones advance upward or downward at about 1 cm/y.1 As Paget’s disease progresses, there is cortical thickening, loss of corticomedullary distinction, and accentuated trabecular markings. The last phase of Paget’s disease is primarily sclerotic, with enlargement and thickening of long bones.3
Plain radiographs of Paget’s lesions are usually confirmatory and rarely confused with x-ray findings of other conditions. Scintigraphic bone scans may be used to assess the extent of skeletal involvement.1,2
References
Lyles KW, Siris ES, Singer FR, et al. A clinical approach to diagnosis and management of Paget’s disease of bone. J Bone Miner Res. 2001;16:1379-1387.
Selby PL, Davie MW, Ralston SH, Stone MD, Bone and Tooth Society of Great Britain, National Association for the Relief of Paget&apos;s Disease. Guidelines on the management of Paget&apos;s disease of bone. Bone. 2002;31:366-373.
Siris ES, Roodman GD. Paget’s disease of bone. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003:495-506.
Early-Stage (Lytic) Paget’s Disease in the Skull: Known as “Osteoporosis Circumscripta”
A typical lesion of early-stage Paget’s disease is the resorptive border in the skull known as osteoporosis circumscripta.
Reference
Lyles KW, Siris ES, Singer FR, et al. A clinical approach to diagnosis and management of Paget’s disease of bone. J Bone Miner Res. 2001;16:1379-1387.
The primary objectives of treatment for Paget&apos;s disease should be to relieve current symptoms, prevent progression of the disease and thereby help avoid complications. &gt; 2 times upper limit than normal
6mths prior – reduce hypervascularity in active pagetic disease
The primary objectives of treatment for Paget&apos;s disease should be to relieve current symptoms, prevent progression of the disease and thereby help avoid complications. &gt; 2 times upper limit than normal
6mths prior – reduce hypervascularity in active pagetic disease
The primary objectives of treatment for Paget&apos;s disease should be to relieve current symptoms, prevent progression of the disease and thereby help avoid complications. &gt; 2 times upper limit than normal
6mths prior – reduce hypervascularity in active pagetic disease
H.L in child and adolescence
Platinum ribbon used for prosthesis
Guanine nucleotide binding proteins (G proteins) are membrane-associated, heterotrimeric proteins composed of three subunits: alpha beta ( and gamma G proteins and their receptors (GPCRs) form one of the most prevalent signalling systems in mammalian cells, regulating systems as diverse as sensory perception, cell growth and hormonal regulation
Mono – temporal bone
GNAS (guanine nucleotide-binding protein/α-subunit
Polyostotic fibrous dysplasia
Endocrine dysfunction
Skin hyperpigmentation
Better demarcated expansile lesion with Smooth margin more aggressive
Albers schonberg
Autosomal dominant
Middle ear involved
Middle ear involved
Pt may have systemic symptoms of TB , pale middle ear mucosa
Middle ear involved
Middle ear involved
Caloric test – Reduced /No response
Anti TNF @ infliximab
Electron micro Bierbeck granule
Middle ear involved
Capillary,venule,arteriole arteriesis
Kidney: rapidly progressive glomerulonephritis (75%), leading to chronic kidney failure
Upper airway, eye and ear disease Nose: pain, stuffiness, nosebleeds, rhinitis, crusting, saddle-nose deformity due to a perforated septum
Ears: conductive hearing loss due to auditory tube dysfunction, sensorineural hearing loss (unclear mechanism)
Oral cavity: strawberry gingivitis,[6] underlying bone destruction with loosening of teeth, non-specific ulcerations throughout oral mucosa
Eyes: pseudotumours, scleritis, conjunctivitis, uveitis, episcleritis
Capillary,venule,arteriole arteriesis
Kidney: rapidly progressive glomerulonephritis (75%), leading to chronic kidney failure
Upper airway, eye and ear disease Nose: pain, stuffiness, nosebleeds, rhinitis, crusting, saddle-nose deformity due to a perforated septum
Ears: conductive hearing loss due to auditory tube dysfunction, sensorineural hearing loss (unclear mechanism)
Oral cavity: strawberry gingivitis,[6] underlying bone destruction with loosening of teeth, non-specific ulcerations throughout oral mucosa
Eyes: pseudotumours, scleritis, conjunctivitis, uveitis, episcleritis
Middle ear involved
Middle ear involved
Exact etiology unknown
89% involves pinna.
cartilagenous portion-Flopp pinna
ET involve: OME